22-50739323-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001097.3(ACR):c.130G>A(p.Val44Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000379 in 1,607,574 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001097.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ACR | NM_001097.3 | c.130G>A | p.Val44Ile | missense_variant | 2/5 | ENST00000216139.10 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ACR | ENST00000216139.10 | c.130G>A | p.Val44Ile | missense_variant | 2/5 | 1 | NM_001097.3 | P1 | |
ACR | ENST00000533930.1 | n.170G>A | non_coding_transcript_exon_variant | 2/3 | 1 | ||||
ACR | ENST00000529621.1 | c.130G>A | p.Val44Ile | missense_variant | 2/4 | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152258Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000418 AC: 10AN: 239212Hom.: 0 AF XY: 0.0000386 AC XY: 5AN XY: 129450
GnomAD4 exome AF: 0.0000378 AC: 55AN: 1455198Hom.: 0 Cov.: 31 AF XY: 0.0000401 AC XY: 29AN XY: 723224
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152376Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74506
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 19, 2023 | The c.130G>A (p.V44I) alteration is located in exon 2 (coding exon 2) of the ACR gene. This alteration results from a G to A substitution at nucleotide position 130, causing the valine (V) at amino acid position 44 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at